The Patent Finder

Guangdong Moltech Pharma Co. Ltd.

Also on record
Records under this name other than patents Guangdong Moltech Pharma Co. Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 2 of 2 · Back to Guangdong Moltech Pharma Co. Ltd.

PatentTitleStatus Expires Confidence
US 10,487,058Cyclopropyl unsaturated quinoline compound used as leukotriene receptor antagonist and applications thereof
Lapsed on the fee record
Ended Nov 26, 2023 · From the USPTO record
Lapsed on the fee recordEnded Nov 26, 2023From the USPTO record
US 10,315,997Cyclopropyl unsaturated quinoline compound used as leukotriene receptor antagonist and applications thereof
Lapsed on the fee record
Ended Jun 11, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jun 11, 2023From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited